Author | Robert A. Dowling, MD


Open Payments and urology: What do the latest data reveal?

September 07, 2020

"Three products alone used to treat advanced prostate cancer were associated with about half of all payments to urologists," writes Robert A. Dowling, MD.

How to use data to measure adherence to clinical guidelines in prostate cancer

August 17, 2020

Against the backdrop of a new guideline for advanced prostate cancer, Robert A. Dowling, MD, describes how you might measure adherence to guidelines in your own practice.

Denosumab tops spending for common urology Part B drugs

June 16, 2020

Mitomycin sees the largest annual growth in spending per dose over the past 5 years, Robert A. Dowling, MD, reports.

Four lessons urology practices can learn from the pandemic

April 17, 2020

Replacing office visits with virtual visits may become the new normal, writes Robert A. Dowling, MD.